$2.16
$-0.09 (-4.00%)
End-of-day quote: 05/16/2024
NasdaqCM:ACXP
Acurx Pharmaceuticals Annual Report
Year | Year | 2022 | |||
---|---|---|---|---|---|
Rev. | Revenue |
|
$0.00M | ||
GM % | Gross Margin % |
|
0.00% | ||
OM | Operating Margin |
|
0.00% | ||
EPS | Earnings Per Share |
|
$0.00 | $-1.15 | $-1.12 |
Div. | Dividends |
|
$0.00 | ||
PR % | Payout Ratio % |
|
0 | ||
Sha. | Shares |
|
11.63m | ||
OCF | Operating Cash Flow |
|
$-7.54M | ||
FCF | Free Cash Flow |
|
$0.00M | ||
FCFS | Free Cash Flow Per Share |
|
$-0.70 |